OBJECTIVE: Impulsive-aggressive behaviors have been consistently implicated in the phenomenology, neurobiology, and familial aggregation of suicidal behavior. The purpose of this study was to extend previous work by examining laboratory behavioral measures of delayed reward impulsivity and impulsive aggression in adolescent suicide attempters and never-suicidal comparison subjects. METHODS: Using the Point Subtraction Aggression Paradigm (PSAP) and the Delay Discounting Task (DDQ), the authors examined delay discounting and impulsive aggression in 40 adolescent suicide attempters, ages 13-18, and 40 never-suicidal, demographically matched psychiatric comparison subjects. RESULTS: Overall, suicide attempters and comparison subjects performed similarly on the PSAP and DDQ. There was a significant group by current psychotropic medication use interaction (p=0.013) for mean aggressive responses on the PSAP. Group comparisons revealed that attempters emitted more aggressive responses per provocation than comparison subjects, only in those not on psychotropic medication (p=0.049), whereas for those currently treated with psychotropic medication, there were no group differences (p>0.05). This interaction effect was specific to current antidepressant use. Among all subjects, family history of suicidal behavior (suicide or suicide attempt) in first degree relatives was significantly correlated with both delay discounting (r=-0.22, p=0.049), and aggressive responding (r=0.27, p=0.015). Family history of suicidal behavior was associated with delay discounting, but not with aggressive responding on the PSAP, after controlling for relevant covariates. CONCLUSIONS: In this study, impulsive-aggressive responding was associated with suicide attempt only in those not being treated with antidepressants. Future work to replicate and extend these findings could have important therapeutic implications for the treatment of depressed suicide attempters, many of whom are affected by impulsive aggression.
OBJECTIVE:Impulsive-aggressive behaviors have been consistently implicated in the phenomenology, neurobiology, and familial aggregation of suicidal behavior. The purpose of this study was to extend previous work by examining laboratory behavioral measures of delayed reward impulsivity and impulsive aggression in adolescent suicide attempters and never-suicidal comparison subjects. METHODS: Using the Point Subtraction Aggression Paradigm (PSAP) and the Delay Discounting Task (DDQ), the authors examined delay discounting and impulsive aggression in 40 adolescent suicide attempters, ages 13-18, and 40 never-suicidal, demographically matched psychiatric comparison subjects. RESULTS: Overall, suicide attempters and comparison subjects performed similarly on the PSAP and DDQ. There was a significant group by current psychotropic medication use interaction (p=0.013) for mean aggressive responses on the PSAP. Group comparisons revealed that attempters emitted more aggressive responses per provocation than comparison subjects, only in those not on psychotropic medication (p=0.049), whereas for those currently treated with psychotropic medication, there were no group differences (p>0.05). This interaction effect was specific to current antidepressant use. Among all subjects, family history of suicidal behavior (suicide or suicide attempt) in first degree relatives was significantly correlated with both delay discounting (r=-0.22, p=0.049), and aggressive responding (r=0.27, p=0.015). Family history of suicidal behavior was associated with delay discounting, but not with aggressive responding on the PSAP, after controlling for relevant covariates. CONCLUSIONS: In this study, impulsive-aggressive responding was associated with suicide attempt only in those not being treated with antidepressants. Future work to replicate and extend these findings could have important therapeutic implications for the treatment of depressed suicide attempters, many of whom are affected by impulsive aggression.
Authors: John G Keilp; Marianne Gorlyn; Maria A Oquendo; Beth Brodsky; Steven P Ellis; Barbara Stanley; J John Mann Journal: Psychol Med Date: 2006-09-07 Impact factor: 7.723
Authors: J John Mann; Victoria A Arango; Shelli Avenevoli; David A Brent; Frances A Champagne; Paula Clayton; Dianne Currier; Donald M Dougherty; Fatemah Haghighi; Susan E Hodge; Joel Kleinman; Thomas Lehner; Francis McMahon; Eve K Mościcki; Maria A Oquendo; Ganshayam N Pandey; Jane Pearson; Barbara Stanley; Joseph Terwilliger; Amy Wenzel Journal: Biol Psychiatry Date: 2009-02-07 Impact factor: 13.382
Authors: David A Brent; Maria Oquendo; Boris Birmaher; Laurence Greenhill; David Kolko; Barbara Stanley; Jamie Zelazny; Beth Brodsky; Jeffrey Bridge; Steve Ellis; J Octavio Salazar; J John Mann Journal: Arch Gen Psychiatry Date: 2002-09
Authors: Richard T Liu; Zoë M Trout; Evelyn M Hernandez; Shayna M Cheek; Nimesha Gerlus Journal: Neurosci Biobehav Rev Date: 2017-09-18 Impact factor: 8.989
Authors: Aliona Tsypes; Katalin Szanto; Jeffrey A Bridge; Vanessa M Brown; John G Keilp; Alexandre Y Dombrovski Journal: J Psychopathol Clin Sci Date: 2021-11-29
Authors: Ingeborg Lunde; Marte Myhre Reigstad; Kristin Frisch Moe; Tine K Grimholt Journal: Int J Environ Res Public Health Date: 2018-05-08 Impact factor: 3.390
Authors: Jason D Jones; Rhonda C Boyd; Monica E Calkins; Tyler M Moore; Annisa Ahmed; Ran Barzilay; Tami D Benton; Raquel E Gur; Ruben C Gur Journal: J Child Psychol Psychiatry Date: 2020-03-30 Impact factor: 8.982